During the past decade, CCOP - Michigan Cancer Research Consortium conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 226 clinical trials were completed, i.e. on average, 1329.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 57 clinical trials were completed. i.e. 1140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Michigan Cancer Research Consortium" #1 sponsor was "National Cancer Institute (NCI)" with 99 trials, followed by "Alliance for Clinical Trials in Oncology" with 91 trials sponsored, "SWOG Cancer Research Network" with 70 trials sponsored, "Gynecologic Oncology Group" with 24 trials sponsored and "Eastern Cooperative Oncology Group" with 24 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Michigan Cancer Research Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 278 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "Cancer and Leukemia Group B" with 22 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator and "NCIC Clinical Trials Group" with 16 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Michigan Cancer Research Consortium" are "Breast Cancer" (58 trials), "Lung Cancer" (36 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (21 trials), "Lymphoma" (17 trials) and "Prostate Cancer" (17 trials). Many other conditions were trialed in "CCOP - Michigan Cancer Research Consortium" in a lesser frequency.

Most popular intervention types in "CCOP - Michigan Cancer Research Consortium" are "Drug" (310 trials), "Other" (158 trials), "Biological" (116 trials), "Radiation" (58 trials) and "Procedure" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "placebo" (38 trials), "Quality-of-Life Assessment" (37 trials), "radiation therapy" (34 trials) and "Paclitaxel" (30 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Michigan Cancer Research Consortium" are 255 trials for "All" genders, 107 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Michigan Cancer Research Consortium". undefined are not yet recruiting, 4 are recruiting, 63 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 270 completed trials in CCOP - Michigan Cancer Research Consortium, undefined suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Michigan Cancer Research Consortium, 16 "Phase 1" clinical trials were conducted, 187 "Phase 2" clinical trials and 162 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".